Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Dose-Finding Study of Abaloparatide in Postmenopausal Osteoporosis
NCT00542425Phase 2Completed
- Sponsor
- Radius Health Inc
- Start
- Apr 2007
- Primary completion
- Jun 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of abaloparatide in postmenopausal osteoporosis, sponsored by Radius Health Inc. Started Apr 2007; status: completed.
02
Drugs
abaloparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00542425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542425.